Related Experiment Video
Updated: Jul 25, 2026
09:31
Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
Gene therapy for juvenile rheumatoid arthritis?
A V Londino1, D Rothman, P D Robbins
1Department of Medicine, Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pennsylvania, USA.
The Journal of Rheumatology. Supplement
|April 27, 2000
Summary
Gene therapy offers potential for treating rheumatic diseases like rheumatoid arthritis (RA). For juvenile RA, a cautious approach is advised, potentially starting with severe cases in children.
Area of Science:
- Rheumatology
- Molecular Biology
- Pediatrics
Background:
- Rheumatic diseases, including rheumatoid arthritis (RA), are a significant health concern.
- Gene therapy is emerging as a novel therapeutic strategy for various conditions.
- Current research explores gene therapy's application in adult RA treatment.
Purpose of the Study:
- To review the advancements in gene therapy for rheumatic diseases.
- To evaluate the potential of gene therapy for treating juvenile rheumatoid arthritis (jRA).
- To discuss the considerations for applying experimental gene therapy in pediatric patients.
Main Methods:
- Literature review of gene therapy studies in rheumatic diseases.
- Analysis of the challenges and benefits of extending gene therapy to juvenile RA.
- Discussion of safety considerations for pediatric gene therapy.
Main Results:
- Gene therapy demonstrates promise for adult RA treatment.
- Extending gene therapy to jRA requires careful consideration of pediatric-specific issues.
- Severe, nonremitting pauciarticular jRA cases may be initial candidates.
Conclusions:
- Gene therapy holds potential for treating juvenile RA.
- A cautious, phased approach, prioritizing safety, is essential for pediatric gene therapy.
- Identifying suitable patient cohorts, such as those with severe jRA, is crucial for initial trials.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...